Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rib-X Counting On Rational Drug Design To Outsmart Resistant Bacteria

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

Three years after creating its RX-04 discovery platform, Rib-X Pharmaceuticals Inc. has vetted 1,400 compounds, tuned them for efficacy against multi-drug resistant bacteria, and is in the process of selecting a handful of candidates to prep for an IND in 2012.
Advertisement

Related Content

Re-Named Melinta Moving Ahead With Delafloxacin And Novel Class Of Antibiotics
Antibiotic Legislation Offers Big GAIN For Small Firm: Rib-X Extends Delafloxacin Exclusivity
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2011
Novel Antibiotics At ICAAC Spur Optimism On Resistance Front
Novel Antibiotics At ICAAC Spur Optimism On Resistance Front
Novel Antibiotics At ICAAC Spur Optimism On Resistance Front
Rib-X Teams With Sanofi To Develop Novel, Broad-Spectrum Antibiotics
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

Topics

Advertisement
UsernamePublicRestriction

Register

PS004850

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel